LBBW Aktienanleihe OMV 25.07.2025/ DE000LB4Z251 /
15/11/2024 17:15:09 | Var.+0.670 | Denaro17:20:42 | Lettera17:20:42 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
92.530EUR | +0.73% | - Quantità in denaro: - |
- Quantità in lettera: - |
OMV AG | 40.00 EUR | 25/07/2025 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center